Jiangsu Hengrui Pharmaceuticals Co.,Ltd (1276.HK) stock price, financials & research

Regular session · HKT · Market data may be delayed.

Company profile

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Headquarters: CN
CEO: Feng Ji
Listed since: May 23, 2025
Employees: 20,602

Market position

Day range

Current HK$46.46

HK$46.04HK$49.00

52-week range

Current HK$46.46

HK$46.04HK$95.20

Open: HK$48.30
Previous close: HK$48.20
Volume: 12.03M; 2.78× average
Average volume: 4.33M; Average daily volume
Market cap: 308.36B HKD
Beta: 0.12; Market reference 1
50-day average: HK$56.4632; -17.72% below average
200-day average: HK$65.1358; -28.67% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 417.15B HKD
P/E (TTM): 39.63×
P/B (TTM): 4.79×
P/S (TTM): 9.52×
EV / EBITDA: 39.19×
Earnings yield: 1.85%
Free cash flow yield: 1.99%
Dividend yield: 0.43%

Profitability & efficiency

Gross margin: 85.34%
Operating margin: 23.92%
Net margin: 24.67%
Return on equity: 12.58%
Return on assets: 11.04%
Return on invested capital: 12.55%

Financial health

Debt / equity: 0.01×
Current ratio: 8.08×
Altman Z-score: 33.48
Piotroski F-score: 4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

35.19B HKD+18.20%

Operating income

10B HKD+25.51%

Net income

8.58B HKD+27.26%

Metric (HKD)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	35.19B HKD	29.77B HKD	25.26B HKD	24.23B HKD	31.02B HKD
Cost of goods sold	4.85B HKD	4.09B HKD	3.9B HKD	3.97B HKD	4.82B HKD
Gross profit	30.33B HKD	25.68B HKD	21.36B HKD	20.26B HKD	26.2B HKD
Research and development	7.74B HKD	7B HKD	5.48B HKD	5.57B HKD	6.92B HKD
Selling, general, and administrative	8.19B HKD	7.68B HKD	7.16B HKD	7.07B HKD	14.68B HKD
Operating expenses	20.33B HKD	17.71B HKD	15.92B HKD	15.58B HKD	21.66B HKD
Interest income	873.74M HKD	641.77M HKD	528.1M HKD	438.8M HKD	708.47M HKD
Interest expense	15.96M HKD	5.91M HKD	6.53M HKD	7.39M HKD	8.54M HKD
Depreciation and amortization	939.8M HKD	825.54M HKD	779.89M HKD	658.17M HKD	651.7M HKD
Operating income	10B HKD	7.97B HKD	5.43B HKD	4.68B HKD	4.54B HKD
Net income	8.58B HKD	6.74B HKD	4.76B HKD	4.45B HKD	5.46B HKD